Spanish company focused on the development of efficacy bioassays seeks subcontracting opportunities from companies in cosmetic, food, nutraceutical and pharma sectors

OFFER from Spain, reference: BOES20181112001, valid from 15-11-2018 untill 04-10-2020

  • Start date:
    15 november 2018
  • End date:
    4 oktober 2020 (4 weken geleden)
  • Summary:
    This Spanish contract research organization is focused on the development of efficacy bioassays and functional validation of ingredients and products through in vitro, ex vivo and in vivo R&D assays, for the cosmetic, food-nutraceutical and pharma industries. The firm is looking for companies interested in subcontracting its services and capacities.
  • Description:
    This company, located in Spain, provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.

    Using different platforms, their studies allow determining the efficacy of active ingredients and final products, validating the functionality and mechanism of action in a novel, rigorous, cost-effective and timely manner.

    The mission of the enterpise is to help companies in their R&D activities through counselling, design and development of efficacy and functionality assays for their active ingredients or end products. They validate companies’ products claims using in vitro, ex vivo & in vivo bioassays: UV/IR/HEV Protection, antioxidant, slimming activity, glucose levels, fat metabolism, detoxifying and antiaging, anti-wrinkles, whitening, anti-irritation, firming, moisturizing, anti-pollution, cell regeneration and proliferation, epigenetics, anti-hair loss, etc.

    Their main values are the quality (rigoruous and through scientific final report), short-time response (mean delivery time, 22 days) and flexibility with better assay conditions (replicates).

    The company develops customized solutions based on the problems and needs of each customer. Constant communication and collaboration with their clients ensures satisfactory solutions to their needs by accessing the latest scientific knowledge, equipment and techniques.

    The company is looking for clients/partners interested in the functional validation of ingredients and products through in vitro, ex vivo and in vivo R&D assays, for cosmetic, food-nutraceutical and pharma industries. The type of cooperation could be mainly a Subcontracting co-operation.
Partner Sought
  • Type of Partnership Considered:
  • Technical Specification or Expertise Sought:

    The company is looking for a co-operation directly related with the functional validation of ingredients and products through in vitro, ex vivo and in vivo R&D assays, for cosmetic, food-nutraceutical and pharma industries. Therefore the partners sought are cosmetic and food-nutraceutical companies or any company that is going to develop a cosmetic or functional food and needs this to sebcontract these services the firm is providing.

    SME 11-50,R&D Institution,SME <10,SME 51-250

  • Development stage:
    Already on the market
  • IPR Status:
    Secret Know-how,Patents granted,Trade Marks,Copyright
  • Market keywords:
    Other medical/health related (not elsewhere classified)
  • Technology keywords:
    Medical Research
    Medical Technology / Biomedical Engineering
  • NACE keywords:
    Research and experimental development on biotechnology
    Other human health activities
  • Advantages and Innovations:
    The most important advantages and innovations of the company are the quality: their rigorous and thorough scientific final report. Also the short-time response: 4-6 weeks (report’s mean delivery time 22 days). The flexibility and better assay conditions (more replicates for a better statistical analysis) must be also outstanding, as the unique capabilities for in vitro testing of both active ingredients and final products (Undiluted). Other advantage would be the excellent quality / price ratio and the know-how with more than 25 years of experience in national and international research. The Cutting-edge equipment and techniques (RT-qPCR, UPLC-MS/MS, Flow Citometry, NGS, Confocal microscopy and screening, miRNA analysis, FRET, NMR, bioinformatics…), and the quick and continous feedback: Client counselling and reporting. Another innovation is the adaptability: tailor-made and ongoing development of new assays. And finally the permanent collaboration with hospitals.
    Furthermore, the company is developing currently two International R&D projects.

    All the above shows the high R & D level developed by the company, which not only innovates in the improvement of new efficiency studies to expand its catalogue, but also actively participates in international R & D projects.
  • Type and Size of Organisation:
    Industry SME <= 10
  • Already Engaged in Trans-National Cooperation
  • Year Established:
  • Turnover:
  • Country of origin:
  • Languages spoken
    • English
    • Spanish